Experimental and Clinical Psychopharmacology publishes advances in translational and interdisciplinary research on psychopharmacology and drug abuse. The scope of research in these areas continues to expand and to benefit from collaborations across a broad range of disciplines, including behavioral science, brain imaging, genetics, neuroendocrinology, neuroscience, and pharmacology. One goal of the journal is to encourage increased attention to biologic factors that may influence both the pharmacodynamic and the pharmacokinetic effects of drugs. Recent research has shown the importance of examining the effects of gender and menstrual/estrous cycle phase on the effects of abused drugs, as well as responses to medications for the treatment of drug abuse and the alleviation of pain.
| YEAR | Impact Factor |
|---|---|
| 2024-25 | 2.2 |
| 2023 | 2.4 |
| 2022 | 2.3 |
| 2021 | 3.492 |
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 1064-1297, AMER PSYCHOLOGICAL ASSOC, Medicine,Pharmacology, Toxicology and Pharmaceutics.